Oscar Health Announces Results for Fourth Quarter and Full Year 2021
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- Wall St slides as oil hovers near $100 on rising Middle East tensions
- Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
- Oil nears $100 as fresh Middle East strikes raise supply risks
- How big a risk are rates to the AI boom?
- 3 reasons why S&P 500 may drop up to 10% in the near term: RBC
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Oscar Health Inc (OSCR) PT Lowered to $8 at Cowen
February 11, 2022 7:10 AM ESTCowen analyst Gary Taylor lowered the price target on Oscar Health Inc (NYSE: OSCR) to $8.00 (from $15.00) while maintaining a Market Perform rating.
The analyst commented, "On 1/27/22 OSCR previewed 4Q21 results and initiated 2022 guidance. Full results tonight reveal a $40m PDR benefit in 4Q21;... More
Oscar Health Inc. (OSCR) Tops Q4 EPS by 12c
February 10, 2022 4:28 PM ESTOscar Health Inc. (NYSE: OSCR) reported Q4 EPS of ($0.95), $0.12 better than the analyst estimate of ($1.07). Revenue for the quarter came in at $496.07 million, versus $157.67 million reported last year.
Direct and assumed premiums of $3,437 million, a 50% increase YoYPremiums earned of $1,831 million, a 302%... More